UBS Group
OSTX

UBS Group’s OS Therapies Inc OSTX Stock Holding History

UBS Group’s Portfolio OSTX Stock Details OSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.7K Sell
8,813
-339,865
-97% -$570K ﹤0.01% 8260
2026
Q1 		$492K Buy
348,678
+330,522
+1,820% +$469K ﹤0.01% 6101
2025
Q4 		$25.4K Buy
18,156
+17,929
+7,898% +$32.3K ﹤0.01% 7625
2025
Q3 		$445 Sell
227
-52,590
-100% -$104K ﹤0.01% 9675
2025
Q2 		$99.3K Buy
+52,817
New +$89K ﹤0.01% 7247
2024
Q4 		– Sell
-3,806
Closed -$10.7K – 10503
2024
Q3 		$10.7K Buy
+3,806
New +$13.6K ﹤0.01% 7716

Other funds holding OSTX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group's OSTX Position: Q2 2026 in Review

UBS Group reduced its OS Therapies Inc (OSTX) stake by 97% in Q2 2026, selling an estimated $570K and leaving 8,813 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #8260.

UBS Group first reported a position in OSTX in Q3 2024 and has held it in 6 quarters since. The position peaked at $492K in Q1 2026. 29 funds tracked by Wall St. Rank hold OSTX as of Q2 2026.

  • UBS Group held 8,813 shares of OS Therapies Inc worth $16.7K as of Q2 2026.
  • UBS Group sold 339,865 OS Therapies Inc shares in Q2 2026, an estimated $570K.
  • OS Therapies Inc made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8260 holding.
  • UBS Group first reported a position in OS Therapies Inc in Q3 2024 and has held it in 6 quarters since.
  • UBS Group's OS Therapies Inc position peaked at $492K in Q1 2026.
  • 29 funds tracked by Wall St. Rank held OS Therapies Inc as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.